KBI Biopharma
Durham, NC · Boulder, CO
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
84.1
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
✓ MHRA GMP (1)
✓ HC GMP (8)
Quick Facts: KBI Biopharma
- Signal Score
- 84.1/100 (as of 2026-10-29)
- Quality Compliance
- 98.5/100
- Headquarters
- Durham, NC · Boulder, CO
- Website
- https://kbibiopharma.com
- Modalities
- Monoclonal Antibody, Recombinant Protein, AAV (analytical only), Plasmid DNA
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About KBI Biopharma
JSR Corporation subsidiary.
Signal Score & Pillar Breakdown
Quality Compliance
98.5
FDA Inspections2 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2026-04-01)
MHRA GMP Certificates1 on record
Most Recent HC OutcomeCompliant · 2026-03-24
HC Attribution8 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Recombinant Protein, AAV (analytical only), Plasmid DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
75.0
Strong parent backing: JSR Corporation
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Strong parent backing: JSR Corporation
Capacity
68.0
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Durham, NC, Boulder, CO
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
StatusLimited
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Durham, NC, Boulder, CO
2 manufacturing sites
Broad modality coverage (4 modalities)
KBI Biopharma FDA Inspection History
2026-04
2021-12
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2026-04-01 |
KBI Biopharma, Inc.
Durham, North Carolina
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2021-12-03 |
KBI Biopharma, Inc.
Boulder, Colorado
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
KBI Biopharma MHRA GMP Compliance 1 certificates
2017-07
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK GMP 48619 Insp GMP 48619/17462240-0001[H] | KBI BIOPHARMA BOULDER | 80301 | 2017-07-31 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
biologics · 2 sites
- Boulder, United States · KBI Biopharma, Inc. (Boulder) — biologics · valid to Dec 1, 2029
- Durham, United States · KBI Biopharma, Inc. (Durham) — biologics · valid to Dec 1, 2029
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity 97+ open roles Beta
From public job postings on KBI Biopharma's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
97+
open roles (the board lists only its ~100 newest)
77
in manufacturing, quality, PD/MSAT, engineering or regulatory (79%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 5 new postings, 0 taken down.
By function
By site
Durham, NC, USA (Hamlin Rd)
profile site
32 mfg/ops · 15 QA/QC · 6 PD/MSAT · 11 eng. · 10 other 74
32 mfg/ops · 15 QA/QC · 6 PD/MSAT · 11 eng. · 10 other 74
Boulder, CO, USA
profile site
2 mfg/ops · 2 QA/QC · 4 PD/MSAT · 1 eng. · 4 other 13
2 mfg/ops · 2 QA/QC · 4 PD/MSAT · 1 eng. · 4 other 13
Remote, NC, USA
· 1 QA/QC · 5 other 6
· 1 QA/QC · 5 other 6
Louisville, CO, USA
· 3 PD/MSAT 3
· 3 PD/MSAT 3
Switzerland - Plan les Ouates
· 1 other 1
· 1 other 1
Modality words in job titles
Biologics (cell culture, USP/DSP)5
Notable roles
Associate Director, Process Development
Senior operations / quality role · Boulder, CO, USA
Senior Director, MS&T
Senior operations / quality role · Durham, NC, USA (National Way)
Sr Director, Quality
Senior operations / quality role · Durham, NC, USA (Hamlin Rd)
Vice President, Facilities, Engineering
Senior operations / quality role · Durham, NC, USA (National Way)
Latest postings
Technical Sales AD Director, Business Development
Commercial, BD & client projects · Remote, CO, USA
Senior Program Manager
Commercial, BD & client projects · Durham, NC, USA (Emperor Blvd)
Scientist I
Process development & MSAT · Louisville, CO, USA
Manager Senior Manager, Manufacturing Investigations
Manufacturing & operations · Boulder, CO, USA
Data Reviewer, Associate Scientist
Process development & MSAT · Durham, NC, USA (Hamlin Rd)
QA Specialist II, 2 2 3 Rotation 12 hour Night Shift
Quality (QA / QC) · Durham, NC, USA (Hamlin Rd)
QA Specialist II, 2 2 3 Rotation 12 hour Day shift
Quality (QA / QC) · Durham, NC, USA (Hamlin Rd)
Supervisor, Manufacturing Support
Manufacturing & operations · Durham, NC, USA (National Way)
Senior Manufacturing Associate II
Manufacturing & operations · Durham, NC, USA (Hamlin Rd)
Senior Manufacturing Associate I II, Night shift
Manufacturing & operations · Durham, NC, USA (Hamlin Rd)
Scientist I
Process development & MSAT · Durham, NC, USA (Hamlin Rd)
QA Specialist II, 2 2 3 Rotation 12 hour Night Shift
Quality (QA / QC) · Durham, NC, USA (Hamlin Rd)
Coverage: counted from KBI Biopharma's own careers board.
The board publishes only its ~100 newest postings, so the real number of open roles is likely higher.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
jsrglobal.wd1.myworkdayjobs.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About KBI Biopharma
How many FDA inspections does KBI Biopharma have on record?
CDMO Signal tracks 2 FDA inspections for KBI Biopharma, sourced from the FDA inspection database. See the full inspection history above.
Has KBI Biopharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for KBI Biopharma.
Does KBI Biopharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for KBI Biopharma.
What is KBI Biopharma's CDMO Signal Score?
KBI Biopharma has a Signal Score of 84/100, based on quality, operations, financial stability, and capacity data.
Evaluating KBI Biopharma for a manufacturing program?
Use the free AI matchmaker to compare KBI Biopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Catalent
Tampa, FL
Signal Score: 76.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Bionova Scientific
Fremont, CA
Signal Score: 59.0
Monoclonal Antibody, Recombinant Protein, Plasmid DNA
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 82.9
Recombinant Protein, Plasmid DNA, mRNA, Microbial Fermentation
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Rentschler Biopharma
Laupheim, Germany
Signal Score: 77.8
Monoclonal Antibody, Recombinant Protein
Compare KBI Biopharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.